Dr. Martens (DOCS) Trading Update summary

Trading performance and outlook

• Trading since the start of the financial year aligns with expectations, with FY25 guidance unchanged.

• Q1 is the smallest period, marking the end of the Spring/Summer season.

• The financial year is expected to be heavily weighted towards the second half, especially for profit.

Strategic focus and initiatives

• The upcoming Autumn/Winter 24 season is a key focus, with detailed trading plans being implemented.

• Targeting positive direct-to-consumer (DTC) growth in the USA during the second half.

• Ongoing work on a cost action plan, with a detailed update to be provided at first half results in November.

Company background

• Dr. Martens is a British brand founded in 1960, known for durable boots and cultural significance.

• Listed on the London Stock Exchange since January 2021 and part of the FTSE 250 index.